Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
Go back to Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026| (NASDAQ: MIRM) | Delayed: 107.77 +0.64 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $107.13 | 52 Week High | $ | |||
| Open | $108.85 | 52 Week Low | $ | |||
| Day High | $109.67 | P/E | N/A | |||
| Day Low | $106.69 | EPS | $ | |||
| Volume | 1,207,238 | |||||

